Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID­19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply.

Aomar-Millán, Ismael Francisco; Salvatierra, Juan; Hernández-Quero, José

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply.

Aomar-Millán, Ismael Francisco; Salvatierra, Juan; Hernández-Quero, José.

Aomar-Millán IF; Department of Internal Medicine, San Cecilio University Hospital, Avda. del Conocimiento s/n, 18016, Granada, Spain. iaomarmillan@hotmail.com.
Salvatierra J; Department of Rheumatology, San Cecilio University Hospital, Granada, Spain.
Hernández-Quero J; Department of Infectious Diseases, San Cecilio University Hospital, Granada, Spain.

Intern Emerg Med ; 16(4): 1105-1106, 2021 06.

Article in English | MEDLINE | ID: covidwho-1126621

Subject(s)

COVID-19 Drug Treatment; Pneumonia; Adrenal Cortex Hormones/therapeutic use; Antibodies, Monoclonal, Humanized; Humans; Interleukin 1 Receptor Antagonist Protein/therapeutic use; Pneumonia/drug therapy; Retrospective Studies; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / COVID-19 Drug Treatment Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Intern Emerg Med Journal subject: Emergency Medicine / Internal Medicine Year: 2021 Document Type: Article Affiliation country: S11739-021-02690-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google